BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14969176)

  • 1. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity.
    Sass MA
    Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
    Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-vial experience with AutoCyte PREP in a small New England regional cytology practice.
    Marino JF; Fremont-Smith M
    J Reprod Med; 2001 Apr; 46(4):353-8. PubMed ID: 11354836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliminating the diagnosis atypical squamous cells of undetermined significance: impact on the accuracy of the Papanicolaou test.
    Sodhani P; Gupta S; Singh V; Sehgal A; Mitra AB
    Acta Cytol; 2004; 48(6):783-7. PubMed ID: 15581162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology.
    Studeman KD; Ioffe OB; Puszkiewicz J; Sauvegeot J; Henry MR
    Acta Cytol; 2003; 47(4):605-10. PubMed ID: 12920754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ThinPrep Pap Test: performance and biopsy follow-up in a university hospital.
    Carpenter AB; Davey DD
    Cancer; 1999 Jun; 87(3):105-12. PubMed ID: 10385440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-based cytology for primary cervical cancer screening: a multi-centre study.
    Monsonego J; Autillo-Touati A; Bergeron C; Dachez R; Liaras J; Saurel J; Zerat L; Chatelain P; Mottot C
    Br J Cancer; 2001 Feb; 84(3):360-6. PubMed ID: 11161401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories.
    Vassilakos P; Saurel J; Rondez R
    Acta Cytol; 1999; 43(1):65-8. PubMed ID: 9987452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsatisfactory SurePath liquid-based Papanicolaou tests: causes and significance.
    Alsharif M; McKeon DM; Gulbahce HE; Savik K; Pambuccian SE
    Cancer; 2009 Feb; 117(1):15-26. PubMed ID: 19347825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
    Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
    Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
    Cox JT
    J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of continuous monitoring of cytologic-histologic correlation data on cervical cancer screening performance.
    Raab SS; Jones BA; Souers R; Tworek JA
    Arch Pathol Lab Med; 2008 Jan; 132(1):16-22. PubMed ID: 18181668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary assessment of the AutoCyte PREP. Direct-to-vial performance.
    Tench W
    J Reprod Med; 2000 Nov; 45(11):912-6. PubMed ID: 11127103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
    Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
    Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of thin-layer preparations vs. conventional Pap smears in a blinded, split-sample study. Extended cytologic evaluation.
    Hessling JJ; Raso DS; Schiffer B; Callicott J; Husain M; Taylor D
    J Reprod Med; 2001 Oct; 46(10):880-6. PubMed ID: 11725731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glandular Cell Abnormalities on SurePath Preparations: A Retrospective Review with Cytology-Histology Correlations.
    Fischer G; Cormier K
    Acta Cytol; 2018; 62(5-6):423-429. PubMed ID: 30244241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.
    Cengel KA; Day SJ; Davis-Devine S; Adams CL; Madison-Henness D; Hartman ME; Freund GG
    Diagn Cytopathol; 2003 Nov; 29(5):250-5. PubMed ID: 14595790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.